Your browser doesn't support javascript.
loading
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols.
Roehrle, Julius; Kasper, Stefan; Treckmann, Jürgen-Walter; Markus, Peter; Schumacher, Brigitte; Albers, David; Wendling, Johanna; Ting, Saskia; Mende, Bastian; Maßmann, Marlene; Markus, Maximilian; Virchow, Isabel; Rosery, Vivian; Laue, Katharina; Zaun, Gregor; Kostbade, Karina; Pogorzelski, Michael; Reissig, Timm M; Liffers, Sven-Thorsten; Schmid, Kurt; Schildhaus, Hans-Ulrich; Schuler, Martin; Siveke, Jens T; Wiesweg, Marcel.
Afiliación
  • Roehrle J; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Kasper S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Treckmann JW; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • Markus P; Department of General, Visceral and Transplant Surgery, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Schumacher B; Department of General Surgery and TraumatologyElisabeth Hospital Essen, Essen, Germany.
  • Albers D; Department of Gastroenterology, Elisabeth Hospital Essen, Essen, Germany.
  • Wendling J; Department of Gastroenterology, Elisabeth Hospital Essen, Essen, Germany.
  • Ting S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Mende B; West German Cancer Center, Institute of Pathology Essen, University Hospital Essen, Essen, Germany.
  • Maßmann M; Central Pharmacy, University Hospital Essen, Essen, Germany.
  • Markus M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Virchow I; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Rosery V; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Laue K; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Zaun G; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Kostbade K; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Pogorzelski M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Reissig TM; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Liffers ST; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Schmid K; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • Schildhaus HU; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Schuler M; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Siveke JT; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Wiesweg M; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Oncol Res Treat ; 46(4): 140-150, 2023.
Article en En | MEDLINE | ID: mdl-36720216
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncol Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncol Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza